A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 2,697,267 shares of NUVL stock, worth $217 Million. This represents 49.52% of its overall portfolio holdings.

Number of Shares
2,697,267
Previous 2,697,267 -0.0%
Holding current value
$217 Million
Previous $205 Million 34.85%
% of portfolio
49.52%
Previous 41.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$72.35 - $88.99 $63.7 Million - $78.3 Million
-880,000 Reduced 24.6%
2,697,267 $203 Million
Q4 2022

Feb 14, 2023

BUY
$18.46 - $36.37 $2.76 Million - $5.43 Million
149,253 Added 4.35%
3,577,267 $107 Million
Q3 2021

Nov 15, 2021

BUY
$18.25 - $38.35 $62.6 Million - $131 Million
3,428,014 New
3,428,014 $77.3 Million

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.45B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.